Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC)
Publication/Presentation Date
10-2019
Volume
30
Issue
5
First Page
404
Last Page
405
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS